Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
BMC Cardiovasc Disord. 2024 Apr 5;24(1):194. doi: 10.1186/s12872-024-03806-1.
High-density lipoprotein cholesterol (HDL-C) is shown to be an independent protective factor against coronary artery diseases (CAD). Yet there are limited studies focusing on the association between HDL-C and coronary artery bypass graft (CABG) surgery outcomes.
Low levels of HDL-C are associated with higher incidence of adverse outcomes in patients undergoing CABG.
This registry-based study included 17,772 patients who underwent elective isolated CABG between 2007 and 2017. Patients were classified into low and desirable HDL-C groups based on their serum HDL-C levels at admission and were followed for one-year post-surgery. The study population included 13,321 patients with low HDL-C and 4,451 with desirable HDL-C. proportional hazard Cox models were performed to evaluate the association between HDL-C levels and incidence of mortality as well as major adverse cardiovascular and cerebrovascular events (MACCE), while adjusting for potential confounders. Moreover, participants were stratified based on sex and the association was also investigated in each subgroup separately.
No significant difference was found between the groups regarding incidence of both mortality and MACCE, after adjusting with Inverse Probability Weighting (IPW) [HR (95%CI): 0.84 (0.46-1.53), p-value:0.575 and HR (95% CI): 0.91 (0.56-1.50), p-value:0.733, respectively]. According to the sex-based subgroup analysis, no significant association was observed after adjustment with IPW analysis. However, as we examined the association between the interaction of HDL-C levels, sex and cardiovascular outcomes, we found a significant association (HR;1.19 (95%CI: 1.04-1.45); p = 0.030).
HDL-C level was not associated with either mortality or MACCE during one year after CABG procedure. Sex-based analysis showed that in males, HDL-C is significantly more protective against these outcomes, compared to females. Further studies are necessary to elucidate the exact mechanisms mediating such association.
高密度脂蛋白胆固醇(HDL-C)被证明是冠心病(CAD)的独立保护因素。然而,目前针对 HDL-C 与冠状动脉旁路移植术(CABG)手术结果之间的关联的研究有限。
HDL-C 水平较低与接受 CABG 手术的患者不良结局的发生率较高有关。
这项基于登记的研究纳入了 2007 年至 2017 年间接受择期单纯 CABG 的 17772 名患者。根据入院时血清 HDL-C 水平,患者被分为低 HDL-C 和理想 HDL-C 组,并在术后一年进行随访。研究人群包括 13321 名低 HDL-C 患者和 4451 名理想 HDL-C 患者。采用比例风险 Cox 模型评估 HDL-C 水平与死亡率和主要不良心血管和脑血管事件(MACCE)发生率之间的关系,同时调整潜在混杂因素。此外,根据性别对参与者进行分层,并分别在每个亚组中研究该关联。
在调整逆概率加权(Inverse Probability Weighting,IPW)后,两组之间死亡率和 MACCE 的发生率均无显著差异[调整后 HR(95%CI):0.84(0.46-1.53),p 值:0.575 和 HR(95%CI):0.91(0.56-1.50),p 值:0.733]。根据基于性别的亚组分析,在调整 IPW 分析后,未观察到显著关联。然而,当我们检查 HDL-C 水平、性别与心血管结局之间的相互作用与关联时,我们发现存在显著关联(HR;1.19(95%CI:1.04-1.45);p=0.030)。
在 CABG 术后一年期间,HDL-C 水平与死亡率或 MACCE 无关。基于性别的分析表明,与女性相比,男性的 HDL-C 对这些结局的保护作用更显著。需要进一步的研究来阐明介导这种关联的确切机制。